ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      19,255.60
      2.11%
      Dow Jones
      41,503.10
      0.00%
      Brent Oil
      73.925
      2.13%
      Bitcoin
      63,072.67
      2.27%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Caladrius Biosciences Inc (CLBS) Quote

      Caladrius Biosciences Inc

      Caladrius Biosciences Inc (CLBS)

      Celebrus Technologies Plc
      0.4264
      0.00
      (0.00%)
      Closed September 18 4:00PM
      Delayed by 15 minutes
      0.4264
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.4264
      Bid
      0.4264
      Ask
      0.43
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      3.475M
      Previous Close
      0.4264
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      8,150,000
      Dividend Yield
      -
      PE Ratio
      -1.15
      Earnings Per Share (EPS)
      -2.56
      Revenue
      -
      Net Profit
      -20.84M

      About Caladrius Biosciences Inc

      Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the... Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its current product candidates include XOWNA, HONEDRA and CLBS201. Show more

      Sector
      Health & Allied Services,nec
      Industry
      Insurance Carriers, Nec
      Website
      www.caladrius.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      2006

      Ask ADVFN Intelligence (AI)

      CLBS Latest News

      More News

      FeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership

      22 hours ago

      Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics

      Company to commence trading on The Nasdaq Capital Market under Ticker Symbol “LSTA” Lisata has approximately $76 million in cash and investments following transaction close Lisata strengthens...

      September 15 2022
      GlobeNewswire Inc.

      Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics

      BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that, based upon the final vote count certified...

      September 14 2022
      GlobeNewswire Inc.

      Life Sciences Virtual Investor Conference Agenda Announced for September 15th

      NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual...

      September 12 2022
      GlobeNewswire Inc.

      Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022

      BASKING RIDGE, N.J., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing...

      September 08 2022
      GlobeNewswire Inc.

      Caladrius Biosciences’ Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement with Roche to Evaluate CEND-1 in Combination with Immunotherapy to Treat Pancreatic Cancer

      Study to be part of Roche’s Morpheus Platform designed to enable more rapid and efficient development of novel cancer immunotherapy combinations Agreement accelerated by Caladrius’ initial...

      August 10 2022
      GlobeNewswire Inc.

      Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update

      Merger with Cend Therapeutics remains on track to close in the third quarter of 2022, subject to stockholder approval, resulting in the formation of Lisata Therapeutics Conference call begins...

      August 04 2022
      GlobeNewswire Inc.

      Caladrius Biosciences Completes Enrollment in Phase 1b Study of CLBS201 for the Treatment of Diabetic Kidney Disease

      BASKING RIDGE, N.J., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative...

      August 02 2022
      GlobeNewswire Inc.

      Caladrius Biosciences to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time

      BASKING RIDGE, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative...

      July 28 2022
      GlobeNewswire Inc.

      Caladrius Biosciences and Cend Therapeutics Announce Publication of Pancreatic Cancer Trial Data in The Lancet Gastroenterology and Hepatology

      BASKING RIDGE, N.J. and SAN DIEGO, July 06, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company...

      July 06 2022
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TBIOTelesis Bio Inc
      $ 3.90
      (186.76%)
      		11.15M
      XCURExicure Inc
      $ 6.00
      (162.01%)
      		4.15M
      ZEOZeo Energy Corporation
      $ 2.79
      (144.74%)
      		4.93M
      VEROVenus Concept Inc
      $ 0.8461
      (68.38%)
      		4.83M
      GLMDGalmed Pharmaceuticals Ltd
      $ 10.23
      (48.26%)
      		3.68M
      PGNYProgyny Inc
      $ 18.52
      (-24.22%)
      		109.32k
      VVOSVivos Therapeutics Inc
      $ 3.28
      (-20.58%)
      		437.67k
      ATMCAlphaTime Acquisition Corporation
      $ 9.00
      (-19.64%)
      		10
      HPAIHelport AI Ltd
      $ 4.78
      (-18.98%)
      		64
      HAOHaoxi Health Technology Ltd
      $ 2.44
      (-18.67%)
      		19.09k
      FRGTFreight Technologies Inc
      $ 0.162
      (30.75%)
      		30.76M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.10
      (10.01%)
      		16.28M
      TBIOTelesis Bio Inc
      $ 3.90
      (186.76%)
      		11.15M
      SQQQProShares UltraPro Short QQQ
      $ 7.88
      (-6.19%)
      		5.87M
      VMARVision Marine Technologies Inc
      $ 0.7282
      (20.76%)
      		5.76M

      Discussion

      View Full Feed
      glenn1919 glenn1919 1 minute ago
      vero...............comm......................................https://www.stockscores.com/charts/charts/?ticker=VERP
      https://www.stockscores.com/charts/charts/?ticker=COMM
      neomania neomania 2 minutes ago
      how would you know what news is coming. You have inside information. This is the stuff they are sorting out in the courts.
      NSAV
      jedijazz jedijazz 2 minutes ago
      $CBDW Green close as expected. Love the way this is trading. @CBDWInc www.cbdw.ai #AI #Biotech #Adnexus
      CBDW
      uksausage uksausage 2 minutes ago
      big financing news, an immediate $40M+ cash from sale/leasing deal on their hydrogen liquefaction/storage equipment.
      FCEL
      Thomas@yahoo Thomas@yahoo 2 minutes ago
      https://hemptoday.net/early-study-shows-epidiolex-may-have-potential-as-treatment-for-illness-in-veterans/
      CVSI
      TrendTrade2016 TrendTrade2016 2 minutes ago
      THE PUMPING CLOWNS THAT ARE PREACHING TO OTHER CLOWNS ABOUT A BILLION SHARE REDUCTION IS AN OLE OTC SCAM...WE SEE IT TIME AND TIME AGAIN....
      ICTY
      jedijazz jedijazz 2 minutes ago
      $CBDW Green close as expected. Love the way this is trading. @CBDWInc www.cbdw.ai #AI #Biotech #Adnexus $NVDA $AVGO
      AVGO CBDW NVDA
      Dantheoneman Dantheoneman 3 minutes ago
      Dude! Did you read News? They are Getting into Significant Revenue Scale without dropping $1 into Deal. This is Multi-Runner. Dollar Status most likely
      SGN
      Penny chatter Penny chatter 3 minutes ago
      Go-ahead and short it
      OMEX
      Tree Tree 3 minutes ago
      Good morning my little wild cards!
      Money hunt Money hunt 3 minutes ago
      And then to the moon dude!! Spacesuit ready!!!
      FOXO
      Huggy Bear Huggy Bear 4 minutes ago
      Don't forget the CONsultants...
      IFUS
      TrendTrade2016 TrendTrade2016 4 minutes ago
      ON THE WEEKLY...MAJOR CONTRADICTION ON LEADING INDICATORS AS THE PUMPING CLOWNS GET THE TENT UP WITH VERY LITTLE SUPPORT...
      ICTY
      koldkash koldkash 5 minutes ago
      SGN has that 1$ feel
      SGN
      Pnypnchr Pnypnchr 5 minutes ago
      Yep that's all this site is good for, drama lies and hopeium.
      AAPJ
      Investor082 Investor082 6 minutes ago
      Nope, not if the approval comes with conditions and no significant backing from big pharma or institutional investor. There is no hiring. So market will not believe LP is serious about commercialization. We could see a less than 50% spike and sell off in the next day or two if there is no major foll
      NWBO
      TrendTrade2016 TrendTrade2016 6 minutes ago
      LETS BRING SOME LIGHT TO THE CLOWN DANCE...FAKE AQUISITION SCAM HERE INTO THE RINSE!!!!
      ICTY
      Emmatf Emmatf 6 minutes ago
      Try BLR https://www.blrtools.com/data-recovery-wizard.html Data Recovery Tool

      BLR Data Recovery Tool is a professional data recovery solution for PC and any Windows-compatible devices. Whether users want to recover lost data from Windows desktop, laptop, or compatible devices such
      USB
      tradernewstip tradernewstip 6 minutes ago
      $LPTH News! LightPath Launches Next Gen Mantis(TM) Camera into $500 Million Global Furnace Monitoring Market
      https://finance.yahoo.com/news/lightpath-launches-next-gen-mantis-123000011.html
      LPTH
      timberwolf7 timberwolf7 7 minutes ago
      oyster: so THIS doesn't count as 'rape'??

      "I remember her saying, here was this person that she was working for and she idolized him," LaCasse said. "And he kind of put her up against a wall. And put his hand up her skirt and he put his fingers inside her. She felt like she was ass
      glenn1919 glenn1919 9 minutes ago
      tbio................................https://stockcharts.com/h-sc/ui?s=TBIO&p=W&b=5&g=0&id=p86431144783
      TBIO
      Newc Newc 9 minutes ago
      Nice. $pbm news
      OHM
      timberwolf7 timberwolf7 10 minutes ago
      satter: ashley bidens diary confirmed to be REAL..

      PS: you have any PROOF of your claims about TRUMP??

      PS: no one but braindead commies like yourself believe whats her name
      there in new york. Why as soon as the rigged trial was over, the commies
      me

      Your Recent History

      NASDAQ
      CLBS
      Caladrius Biosciences
      Delayed Upgrade Clock